Paper Details

  1. Home
  2. Paper Details

Therapeutic developments in cytomegalovirus retinitis.

Author: HoffmanV F, SkiestD J

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

CMV retinitis is an eye infection that can cause vision loss and blindness in people with HIV. Ganciclovir is the traditional treatment, but newer medications like foscarnet, cidofovir, and intraocular ganciclovir implants are also available.
Paper Details　
Original Abstract of the Article :
The incidence of cytomegalovirus (CMV) retinitis in AIDS has declined significantly due to the use of highly active antiretroviral therapy (HAART). However, patients with HIV, especially those failing HAART, may still suffer with CMV retinitis, which can lead to significant loss of vision and blindn...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1517/13543784.9.2.207

データ提供：米国国立医学図書館（NLM）

Cytomegalovirus Retinitis: Navigating the Challenges of Treatment

The world of [cytomegalovirus (CMV) retinitis] is a complex and challenging one, especially for patients with [HIV]. This research explores the latest developments in [therapeutic options] for [CMV retinitis], highlighting the impact of [highly active antiretroviral therapy (HAART)] in reducing the incidence of the disease.

A New Oasis in the Desert of CMV Retinitis

The research discusses the use of various [anti-CMV agents], including [ganciclovir, foscarnet, cidofovir, and intraocular ganciclovir implant]. It also explores the potential of [fomivirsen], a newly approved agent, and the development of new therapies such as [valganciclovir]. These advancements represent a significant step forward in the fight against CMV retinitis, offering new pathways to combat this vision-threatening condition.

Hope for Patients with CMV Retinitis

This research highlights the ongoing progress in the treatment of [CMV retinitis]. The development of new agents and improved therapies offer hope for patients facing this challenging condition. Just as a traveler in a desert finds solace in a hidden spring, patients with CMV retinitis can find hope in these new advances.

Dr.Camel's Conclusion

The research on cytomegalovirus retinitis showcases the advancements in treatment options for this vision-threatening condition. The development of new agents, including ganciclovir, foscarnet, cidofovir, fomivirsen, and valganciclovir, provides hope for patients facing this challenge. This research underscores the relentless pursuit of innovation in the face of medical adversity, offering a beacon of hope for those navigating the desert of CMV retinitis.

Date :
  1. Date Completed 2000-11-30
  2. Date Revised 2019-09-15
Further Info :

Pubmed ID

11060672

DOI: Digital Object Identifier

10.1517/13543784.9.2.207

Related Literature

Article Analysis
・Side Effects of foscarnet injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.